SEC Form 4 · accession 0000899243-18-028966
AMEDISYS INC · AMED
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Paul North
Officer — Chief Information Officer
Period of report
Nov 12, 2018
Accepted (ET)
Nov 14, 2018 · 9:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000896262
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 12, 2018 | M | 2,264 | $32.56 | A | 23,767 | D | |
| Common StockF2,F1 | Nov 12, 2018 | S | 2,264 | $119.30 | D | 21,503 | D | |
| Common StockF1 | Nov 13, 2018 | M | 100 | $32.56 | A | 21,603 | D | |
| Common StockF1 | Nov 13, 2018 | S | 100 | $118.06 | D | 21,503 | D | |
| Common StockF1 | Nov 14, 2018 | M | 3,261 | $32.56 | A | 24,764 | D | |
| Common StockF3,F1 | Nov 14, 2018 | S | 3,261 | $116.36 | D | 21,503 | D | |
| Common StockF4 | holding | — | — | — | 391 | I | Through 401(k) Plan |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F5 | $32.56 | Nov 12, 2018 | M | 2,264 | D | — | Jun 2, 2025 | Common Stock | 2,264 | 9,236 | D |
| Stock Option (right to buy)F5 | $32.56 | Nov 13, 2018 | M | 100 | D | — | Jun 2, 2025 | Common Stock | 100 | 9,136 | D |
| Stock Option (right to buy)F5 | $32.56 | Nov 14, 2018 | M | 3,261 | D | — | Jun 2, 2025 | Common Stock | 3,261 | 5,875 | D |
Explanation of responses
- F1The total amount of shares beneficially owned includes 761 shares held in an employee stock purchase plan account.
- F2The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.00 to $119.80 inclusive. The reporting person undertakes to provide to Amedisys, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
- F3The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.28 to $116.39 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (3) to this Form 4.
- F4The information in this report is based on a plan statement dated as of September 30, 2018.
- F5On June 2, 2015, the reporting person was granted an option to purchase 22,500 shares of common stock. The stock options are subject to time-based vesting conditions. 5,625 of the options vested on each of June 2, 2016, June 2, 2017 and June 2, 2018, and the remaining 5,625 options will vest on June 2, 2019, provided that the reporting person remains continuously employed by the Issuer on such date, subject to pro-rated vesting provisions as provided in the award agreement for the stock option.